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Abstract
TheErlenmeyer flask deformity is a common skeletalmodeling deformity, but current classification systems are binary andmay restrict
its utility as a predictor of associated skeletal conditions. A quantifiable 3-point system of severity classification could improve its
predictive potential in disease. Ratios were derived from volumes of regions of interests drawn in 50 Gaucher’s disease patients. ROIs
were drawn from the distal physis to 2 cm proximal, 2 cm to 4 cm, and 4 cm to 6 cm. Width was also measured at each of these
boundaries. Two readers rated these 100 femurs using a 3-point scale of severity classification.Weighted kappa indicated reliability and
one-way analysis of variance characterized ratio differences across the severity scale. Accuracy analyses allowed determination of
clinical cutoffs for each ratio. Pearson’s correlations assessed the associations of volume andwidthwith a shape-based concavitymetric
of the femur. The volume ratio incorporating themetaphyseal region from 0 to 2 cm and the diametaphyseal region at 4–6 cmwasmost
accurate at distinguishing femurs on the 3-point scale. Receiver operating characteristic curves for this ratio indicated areas of 0.95 to
distinguish normal andmild femurs and 0.93 to distinguishmild and severe femurs. Volumewasmoderately associatedwith the degree
of femur concavity. The proposed volume ratiomethod is an objective, proficient method at distinguishing severities of the Erlenmeyer
flask deformitywith the potential for automation. Thismay have application across diseases associatedwith the deformity and deficient
osteoclast-mediated modeling of growing bone.
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Introduction
Erlenmeyer flask deformities (EFDs) are well-documented in
a multitude of diseases with musculoskeletal involvement,
including osteopetrosis, metaphyseal dysplasia, Gaucher’s,
Niemann-Pick, and achondroplasia [1–3]. Impaired bone re-
modeling due to dysfunctional osteoclasts during skeletal
growth leads to development an undertubulated distal femur,
characterized by a loss of metaphyseal concavity and a wider
metaphysis [4]. The deformity’s name comes from its
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resemblance to the lower portion of an Erlenmeyer flask, al-
though the degree of undertubulation varies across patients.
Previous work has established a highly sensitive and spe-
cific means of objectifying the EFD through taking width
measurements of the femur at certain distances from the
physis and setting width ratios as a cutoff for the deformity
[5]. A ratio > 0.58 between the width at 4 cm and the width at
the physis was reported as being the most robust and accurate
differentiator of EFD from non-EFD femurs against radiolo-
gist ratings. Notably, this differentiation was binary and did
not account for the degree of undertubulation.
Under the current binary system, there have been weak asso-
ciations of the presence or absence of EFD with other skeletal
manifestations in disease such as osteonecrosis, osteosclerosis,
and bone marrow infiltration [1]. Introducing a new, simple sys-
tem that accounts for the degree of severity of EFDmay uncover
associations that enable a better understanding of skeletal dis-
eases. Given the early stage of skeletal development that EFD
manifests [1], this could have remarkable clinical utility for lon-
gitudinal patient monitoring and care plans.
Developing a method of quantifying and differentiating the
deformity requires multiple criteria for maximal utility. It
should, within the EFD positive patients, be able to differen-
tiate mild and severe cases. It should be able to account for the
loss of distal femur concavity in EFD, which has not been
studied in the previous method involving width measure-
ments. It should output analyzable, continuous clinical param-
eters that can be studied in the future against other skeletal
manifestations in disease. And it should have the potential for
semi-automation to derive the classification.
With these criteria as a premise, the aim of this study was to
evaluate a new, more robust method of classifying EFD
through volume ratios against radiologist ratings of “No
EFD”, “Mild EFD”, “Severe EFD”. Additionally, width ratios
were revisited as a means of classifying under this 3-point
system and compared against our findings with volume ratios.
Methods
Image acquisition and demographics
The Gaucherite study was conducted under the approval of the
East of England – Essex Research Ethics Committee (14/EE/
1168) in the UnitedKingdom [6]. All procedures performed in
studies involving human participants were in accordance with
the ethical standards of the institutional and/or national re-
search committee and with the 1964 Helsinki declaration
and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual partic-
ipants included in the study. Consent to use data that was
collected prior to the start of the Gaucherite study was obtain-
ed at patients’ normal NHS medical follow-ups. Patients
signed to confirm that their imaging data could be used both
retrospectively and prospectively as part of their normal clin-
ical management. The consent form states the following: “I
agree that my previously collected medical history, biological
samples and images (such as MRI and DXA) and data col-
lected from the analysis of this material can be used for the
purposes of this research as described in this Information
Sheet and stored for use for future research.”
Coronal T1-weighted 2D Fast Spin Echo (FSE)MRIs were
acquired of diagnosed Gaucher’s patients using 1.5 T MRI
systems between 2008 and 2017 for retrospective analysis.
The voxel size was consistent across the study at 0.94 ×
0.94 mm2, with a pixel bandwidth = ± 12/2 kHz, and with 1
average. Due to the nature of this study, imaging parameters
varied over time and site, including repetition time (TR),
which varied with values of 420, 460, 500, 520, 528, 540,
620, 640, and 800 ms. Similarly, the acquisition matrix
consisted of multiple combinations of 256, 320, 384, or 512,
with common schemes including 256 × 256, 256 × 384,
256 × 320, or 256 × 512. The receive coils included 8-
channel knee coils, 8-channel lower body coils, and 32-
channel cardiac coils. The slices had 1.5, 3, 4, 5, and 6 mm
thicknesses. Other than slice thickness, the shape-based char-
acteristics were chosen for analysis to reduce dependence on
any MRI sequence.
MRI images of the distal femur and knee acquired under
this protocol were evaluated in this study across 50 subjects,
for a total of 100 femurs. There were 24 male and 26 female
participants, of which 9 were Ashkenazi Jew, a population
with a higher risk of Gaucher’s [7]. The age range was 23–
78 years with a mean of 53 years.
Volume and width ratio measurements of the distal
femur
The first phase of the study required drawing regions of inter-
est (ROIs) on the distal femur with a standardized protocol.
LIFEx (LIFEx Soft, v4.00 Orsay, France) was installed to
collect ROIs from the DICOM image files, allow drawing
and the measurement of distances within images (specific to
that image), and output ROI volume measurements [8].
Selection of the slice for drawing included the following
criteria: (1) physis clearly depicted, (2) > 15 cm distal femur
+ epiphysis length present, (3) no flexion deformities which
indicate improper patient positioning [9], and (4) no image
artifacts around the metaphysis. On the selected slice, the
physis was identified and the first ROI was drawn utilizing
the LIFEx drawing and distance measurement tools from the
physis to 2 cm above. The second ROI was drawn from 2 cm
above to 4 cm above, and the third ROI was drawn from 4 to
6 cm (Fig. 1). This process was repeated for both femurs
across all patients. There were multiple instances of different
slices being chosen for right vs. left femurs within the same
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patient due to patient positioning during the scan and subse-
quent image appearance.
Volume was automatically outputted as a variable by
LIFEx upon completion of drawing. It must be noted that
this metric of “Volume” is solely a reflection of the area
of the femur within the ROI multiplied by slice thickness
and does not reflect any further volume of the femur. The
volume metrics for each ROI (0–2 cm from physis, 2–
4 cm from physis, 4–6 cm from physis) were recorded.
Absolute volume measurements were variable between
patients due to varying slices thicknesses from 0.6 to
1.0 mm and the biological size of different femurs.
However, taking the ratio of the volumes in our method-
ology accounted for these variations. Volume ratios were
calculated for each possible volume combination: 2–4 cm/
0–2 cm, 4–6 cm/0–2 cm, and 4–6 cm/2–4 cm.
Width measurements at the physis, 2 cm above, 4 cm
above, and 6 cm above, were taken using the LIFEx distance
measurement tool. Width ratios were calculated for each pos-
sible distance combination, at 2 cm/physis, 4 cm/physis, 6 cm/
physis, 4 cm/2 cm, 6 cm/2 cm, and 6 cm/4 cm.
Radiologist classification of the Erlenmeyer flask
deformity
The second phase of the study was radiologist classification of
the femurs for the EFD. Two readers, one with 12 years of
experience in musculoskeletal radiology (R1) and one with
4 years of experience (R2), independently reviewed each fe-
mur across multiple slices according to standard radiological
practice and rated the femurs by “No EFD”, “Mild EFD”, and
“Severe EFD”. Intra-rater reliability was assessed on R2 by
requesting a repeat of the rating process after 2 weeks.
Statistical analysis
PSPP was used as the software for statistical analysis. Inter-
rater reliability between R1 and R2 in the 3-point rating sys-
tem of EFDwas determined using linear-weighted kappa with
95% confidence intervals (CI). Intra-rater reliability of R2 was
also assessed by linear-weighted kappa with 95% CI.
Further analyses were conducted only on femurs with con-
cordant ratings by R1 and R2. The data was checked for nor-
mality and the one-way analysis of variance (ANOVA) was
conducted between the “No EFD”, “Mild EFD”, and “Severe
EFD” groups to detect significant differences in width ratios
and volume ratios across groups. Box-and-whisker plots were
created for the three volume ratio parameters to visually depict
differences in median and IQR between the three EFD rating
groups. As a sub-analysis, when two readers concordantly
rated the two femurs within the same patient differently, the
average and standard deviation of volume ratio difference be-
tween femurs were calculated.
Based on the initial findings, cutoffs were determined for
each of the volume ratio parameters between the three degrees
of EFD. Accuracy analyses and receiver operating character-
istic (ROC) curves were used to compare proficiency of each
ratio at their respective cutoffs. This was repeated for each of
the ANOVA-significant width ratio parameters. ROC curves
for these width ratios were compared against the ROC curves
for the volume ratios.
Finally, the ability of width ratios and volume ratios
to account for the concavity of the femur was com-
pared. This is the very basis of radiologist classification,
as visually more severe EFD femurs have a greater loss
of concavity (Fig. 1). The ROIs drawn for each femur
were combined into a single ROI (0–6 cm from physis)
and a metric called “SHAPE_Sphericity” was outputted
Fig. 1 Distal femur ROIs to capture the Erlenmeyer flask deformity.
Three ROIs were drawn for each femur: physis to 2 cm above the
physis, 2 cm to 4 cm above the physis, and 4 cm to 6 cm above the
physis. Note that each femur has a different degree of metaphyseal
flaring. The left image is a femur rated “No EFD”, the center “Mild
EFD”, and the right “Severe EFD”
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from these ROIs using the LIFEx 4.00 built-in code for
shape analysis. “SHAPE_Sphericity” is defined by
LIFEx 4.00 as how spherical an ROI is, with a value
of 1 indicating completely spherical [8]. Using
Pearson’s correlation analysis, this metric was associated
with the absolute width measurements at the physis,
2 cm, 4 cm, and 6 cm and volume measurements at
0–2 cm, 2–4 cm, and 4–6 cm, to evaluate for significant
associations and characterize the strength of the
associations.
Results
A total of 300 ROIs were drawn for the 100 femurs in this
study. Figure 1 depicts examples of ROIs at different degrees
of the EFD.
Radiologist classification—inter-rater reliability
Table 1 depicts the spread of EFD ratings across the 3-point
system and allows a subjective assessment of concordance
between R1 and R2.
The linear-weighted kappa statistic between R1 and R2
was 0.81 with a 95% CI of 0.72 to 0.90, indicating a substan-
tial to almost perfect agreement between raters in the classifi-
cation of EFD [10].
Notably, there were 10 patients in which both raters gave
two distinct EFD classifications within the same patient bilat-
erally (i.e. right femur mild, left femur severe) and the raters
matched exactly in 9 of those patients.
Radiologist classification—intra-rater reliability
The linear-weighted kappa statistic between R2’s ratings at
time point 1 and 2 weeks later at time point 2 was 0.86 with
a 95%CI of 0.79 to 0.94. This indicated a substantial to almost
perfect intra-rater reliability in the classification of EFD [10].
Volume and width ratios across EFD severities
Only the 84 femurs with concordant radiologist ratings of
EFD severity were evaluated. One-way ANOVA was con-
ducted to determine the degree to which volume ratios and
width ratios could differentiate among EFD severity (Table 2).
Post hoc analysis with Tukey’s HSD was conducted for the
significant results.
Box-and-whisker plots were created to visually depict the
spread of each volume ratio across the three degrees of EFD
severity (Fig. 2).
Distinct femur ratings within the same patient
The nine patients with rater-concordant, distinct EFD severites
between the right and left femurs were evaluated. All severity
differences were only of one degree (i.e., there were no pa-
tients with one severe and one normal EFD femur). The aver-
age difference in ratios between no EFD vs. mild EFD and
mild EFD vs. severe EFD is presented in Table 3.
Note that from a less severe to more severe femur within
the same patient, the ratio increased in all cases.
Width and volume clinical cutoffs for EFD
Cutoffs were first determined for width ratios. ROC curves were
analyzed for each ratio between normal to mild severity to set
cutoffs maximizing sensitivity (thus minimizing false negatives)
with minimal impact on specificity. ROC curves to set cutoffs
between mild and severe EFD were then analyzed to maximize
specificity and reduce false positives, with minimal impact on
sensitivity. This approach targeted the accurate distinction of
mild EFD cases from normal femurs or severe EFD.
Overall accuracy of each cutoff was assessed using only
femurs rated on either side of the cutoff (i.e., severe EFD
cutoff was evaluated using onlymild and severe EFD femurs).
Note that only width ratios with accuracies > 70% for both
normal to mild and mild to severe distinctions are presented
here in Table 4. The remaining width ratios were not as pro-
ficient at distinguishing severity of EFD and can be found in
Supplementary Table 1. Notably, 0.58 was discussed as the
cutoff for no EFD vs. EFD in the previous study under the
“Width 4 cm/Width Physis” ratio [5]. The cutoff for the same
width ratio in this study was 0.55 for no EFD vs. mild EFD
cases (Supplementary Table 1).
Translatability of volume ratios to clinical cutoffs was
assessed next. Cutoffs optimizing sensitivity between the
Normal and Mild distinction and specificity between the
Mild and Severe distinction were determined by ROC curves.
The accuracy analyses are presented in Table 5.
Subsequently, two ROC curves were obtained for each of
the ratios for the classification of the two degrees of distinc-
tion. Among all ratios, the volume ratios of 4–6 cm/0–2 cm
Table 1 Comparison of radiologist ratings of the Erlenmeyer flask
deformity across a 3-point system of classification
Radiologist 2
No EFD Mild EFD Severe EFD Total
Radiologist 1 No EFD 19 1 0 20
Mild EFD 8 31 3 42
Severe EFD 0 4 34 38
Total 27 36 37 100
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and 2–4 cm/0–2 cm had the largest area under the curve
(AUC) for the no EFD vs. mild EFD distinction (0.95 and
0.92, respectively) as well as the mild EFD vs. severe EFD
distinction (0.93 and 0.90, respectively).
The width ratios of 4 cm/physis and 6 cm/physis showed
strong AUCs of 0.92 and 0.89 for the mild vs. severe distinc-
tion but performed worse at classifying between no EFD and
mild EFD with AUCs of 0.74 and 0.80, respectively.
Table 2 One-way ANOVA of Erlenmeyer flask deformity severity
against volume and width ratios. Ratios with non-overlapping confidence
intervals are in italics. Tukey’s HSD is reported with “EFD 0/1”
representing the comparison between groups with EFD Severity Rating
0 and EFD Severity Rating 1, and similarly for the “EFD 0/2” and “EFD
1/2”
Ratios EFD Severity Rating
(0 = normal, 1 =mild, 2 = severe)
95% confidence interval F-
statistic
p value Tukey’s HSD
Volume 4−6 cm
Volume 0−2 cm 0 0.50–0.55 119.02 < 0.0001 EFD 0/1: 0.099 (p < 0.0001)
1 0.61–0.64 EFD 0/2: 0.202 (p < 0.0001)
2 0.71–0.75 EFD 1/2: 0.103 (p < 0.0001)
Volume 4−6 cm
Volume 2−4 cm 0 0.74–0.79 23.04 < 0.001 EFD 0/1: 0.065 (p < 0.001)
1 0.80–0.85 EFD 0/2: 0.103 (p < 0.0001)
2 0.85–0.88 EFD 1/2: 0.038 (p < 0.05)
Volume 2−4 cm
Volume 0−2 cm 0 0.68–0.71 78.61 < 0.0001 EFD 0/1: 0.067 (p < 0.0001)
1 0.75–0.77 EFD 0/2: 0.153 (p < 0.0001)
2 0.83–0.86 EFD 1/2: 0.086 (p < 0.0001)
Width 2 cm
Width Physis 0 0.70–0.77 20.41 < 0.001 EFD 0/1: not significant
1 0.74–0.78 EFD 0/2: 0.115 (p < 0.0001)
2 0.82–0.88 EFD 1/2: 0.093 (p < 0.0001)
Width 4 cm
Width Physis 0 0.49–0.57 51.89 < 0.001 EFD 0/1: 0.055 (p < 0.05)
1 0.57–0.60 EFD 0/2: 0.194 (p < 0.0001)
2 0.69–0.75 EFD 1/2: 0.139 (p < 0.0001)
Width 6 cm
Width Physis 0 0.39–0.47 54.25 < 0.001 EFD 0/1: 0.082 (p < 0.001)
1 0.49–0.53 EFD 0/2: 0.211 (p < 0.0001)
2 0.61–0.67 EFD 1/2: 0.129 (p < 0.0001)
Width 4 cm
Width 2 cm 0 0.69–0.75 37.79 < 0.001 EFD 0/1: 0.054 (p < 0.01)
1 0.75–0.80 EFD 0/2: 0.13 (p < 0.0001)
2 0.83–0.87 EFD 1/2: 0.077 (p < 0.0001)
Width 6 cm
Width 2 cm 0 0.55–0.61 32.85 < 0.001 EFD 0/1: 0.096 (p < 0.001)
1 0.65–0.71 EFD 0/2: 0.170 (p < 0.0001)
2 0.73–0.77 EFD 1/2: 0.074 (p < 0.001)
Width 6 cm
Width 4 cm 0 0.78–0.84 11.68 < 0.001 EFD 0/1: 0.066 (p < 0.001)
1 0.85–0.90 EFD 0/2: 0.076 (p < 0.0001)
2 0.87–0.90 EFD 1/2: not significant
Fig. 2 Box-and-whisker plots of the three volume ratios across the three EFD severities. a The plot for the ratio “volume 4–6 cm/volume 0–2 cm”. b
“volume 4–6 cm/volume 2–4 cm”. c “volume 2–4 cm/volume 0–2 cm”
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Concavity of the femur predicted by volume and
width ratios
To better understand the distinctness of information that vol-
ume and width capture at classifying degrees of EFD severity,
a Pearson’s correlation analysis on the association of our
width and volume measurements with femur sphericity was
conducted as described in the “Methods”.
All three volume measurements had significant (p < 0.01)
and moderate Pearson’s correlations with sphericity of − 0.42,
Table 4 Accuracy
analyses of width-ratio-
based clinical cutoffs at
differentiating severities
of the Erlenmeyer flask
deformity, with the best
performing ratio in italics
Ratio Severity cutoff Accuracy (95% CI)
Width 6 cm
Width Physis Normal ≥mild (cutoff = 0.47) Sensitivity: 80.7% (62.5–92.6%)
Specificity: 79.0% (54.4–94.0%)
PPV: 86.2% (72.0–93.8%)
NPV: 71.4% (54.0–84.2%)
Accuracy: 80.0% (66.3–90.0%)
Mild ≥ Severe (cutoff = 0.61) Sensitivity: 73.5% (55.6–87.1%)
Specificity: 93.6% (78.6–99.2%)
PPV: 92.6% (76.3–98.0%)
NPV: 76.3% (64.6–85.0%)
Accuracy: 83.1% (71.7–91.2%)
Width 4 cm
Width 2cm Normal ≥mild (cutoff = 0.75) Sensitivity: 77.4% (58.9–90.4%)
Specificity: 79.0% (54.4–94.0%)
PPV: 85.7% (71.1–93.6%)
NPV: 68.2% (51.8–81.1%)
Accuracy: 78.0% (64.0–88.5%)
Mild ≥ severe (cutoff = 0.82) Sensitivity: 76.5% (58.8–89.3%)
Specificity: 83.9% (66.3–94.6%)
PPV: 83.9% (69.5–92.2%)
NPV: 76.5% (63.5–85.9%)
Accuracy: 80.0% (68.2–88.9%)
Width 6 cm
Width 2cm Normal ≥mild (cutoff = 0.61) Sensitivity: 83.9% (66.3–94.6%)
Specificity: 73.7% (48.8–90.9%)
PPV: 83.9% (70.7–91.8%)
NPV: 73.7% (54.6–86.7%)
Accuracy: 80.0% (66.3–90.0%)
Mild ≥ severe (cutoff = 0.72) Sensitivity: 67.7% (49.5–82.6%)
Specificity: 74.2% (55.4–88.1%)
PPV: 74.2% (60.2–84.5%)
NPV: 67.7% (55.2–78.0%)
Accuracy: 70.8% (58.2–81.4%)
PPV positive predictive value, NPV negative predictive value
Table 3 Volume ratios and their ability to distinguish varying severity of the Erlenmeyer flask deformity across femurs within the same patient
Number of patients Average difference
in (volume 4–6 cm/
volume 0–2 cm) ± SD
Average difference in
(volume 4–6 cm/volume
2–4 cm) ± SD
Average difference
in (volume 2–4 cm/
volume 0–2 cm) ± SD
No EFD+mild EFD 3 0.12 ± 0.05 0.07 ± 0.05 0.08 ± 0.07
Mild EFD + severe EFD 6 0.08 ± 0.04 0.03 ± 0.05 0.07 ± 0.03
Total 9 0.09 ± 0.04 0.05 ± 0.05 0.07 ± 0.04
SD standard deviation
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− 0.39, and − 0.37, respectively. The width measurements
showed negligible correlations ranging from − 0.03 to 0.04.
Notably, the volume associations were directionally valid, as a
greater metaphyseal volume seen in EFD indicates loss of
concavity and thereby sphericity.
Discussion
The aim of this study was to introduce a 3-point severity scale
of EFD classification and evaluate the proficiency of volume
ratios at classifying under this scale, compared against width
ratios. Our findings demonstrate that volume ratios incorpo-
rating both the metaphysis and a diametaphyseal region can
best delineate severities of EFD and tend to be more proficient
than width ratios because they account for loss of distal femur
concavity. Several clinical cutoffs based on these volume ra-
tios had high ROC AUCs, suggesting their potential utility
among radiologists to accurately classify EFD severity.
Thus, the degree of EFD severity may be characterized early
in disease and studied more robustly as a predictor of further
skeletal manifestations.
Our 3-point system of EFD classification is functionally
simple and the concordance between our two raters trained
at different institutions with different levels of experience in-
dicates that the system does indeed capture meaningful, dis-
cernible differences. Among the ratios, “volume 4–6 cm/vol-
ume 0–2 cm” lends clinical cutoffs that can best classify EFD
objectively on this scale, ensure the accurate detection of mild
cases of EFD, and may even be used to distinguish variable
femurs within the same patient. The remaining ratios would be
inefficient to use, as they are less proficient at differentiating at
least one of the two thresholds. “Volume 2–4 cm/volume 0–
2 cm”, for example, is weaker at differentiating normal from
mild femurs, suggesting that the distinction between these
severities may be diametaphyseal flaring further from the
Table 5 Accuracy
analyses of volume-
ratio-based clinical cut-
offs at differentiating se-
verities of the
Erlenmeyer flask defor-
mity, with the best
performing ratio in italics
Ratio Severity cutoff Accuracy (95% CI)
Volume 4−6 cm
Volume 0−2 cm Normal ≥mild (cutoff = 0.57) Sensitivity: 96.8% (83.3–99.9%)
Specificity: 84.2% (60.4–96.6%)
PPV: 90.9% (77.9–96.6%)
NPV: 94.1% (69.7–99.1%)
Accuracy: 92.0% (80.8–97.8%)
Mild ≥ severe (cutoff = 0.68) Sensitivity: 82.4% (65.5–93.2%)
Specificity: 90.3% (74.3–98.0%)
PPV: 90.3% (75.9–96.5%)
NPV: 82.4% (69.1–90.7%)
Accuracy: 86.2% (75.3–93.5%)
Volume 4−6 cm
Volume 2−4 cm Normal ≥mild (cutoff = 0.79) Sensitivity: 77.4% (58.9–90.4%)
Specificity: 73.7% (48.8–90.9%)
PPV: 82.8% (68.8–91.3%)
NPV: 66.7% (49.7–80.2%)
Accuracy: 76.0% (61.8–86.9%)
Mild ≥ severe (cutoff = 0.85) Sensitivity: 61.8% (43.6–77.8%)
Specificity: 71.0% (52.0–85.8%)
PPV: 70.0% (55.9–81.1%)
NPV: 62.9% (51.1–73.3%)
Accuracy: 66.2% (53.4–77.4%)
Volume 2−4 cm
Volume 0−2 cm Normal ≥mild (cutoff = 0.72) Sensitivity: 83.9% (66.3–94.6%)
Specificity: 79.0% (54.4–94.0%)
PPV: 86.7% (72.9–94.0%)
NPV: 75.0% (56.5–87.4%)
Accuracy: 82.0% (68.6–91.4%)
Mild ≥ severe (cutoff = 0.80) Sensitivity: 76.5% (58.8–89.3%)
Specificity: 96.8% (83.3–99.9%)
PPV: 96.3% (78.9–99.5%)
NPV: 79.0% (67.1–87.3%)
Accuracy: 86.2% (75.3–93.5%)
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physis. Similarly, the relative inability of “volume 4–6 cm/
volume 2–4 cm” to classify EFD accurately may be due to
its lack of metaphyseal volume information. The overall
weaker performance of width ratios, especially with the nor-
mal to mild distinction, is also notable and may be explained
by their inability to detect loss of concavity.
While the presence of EFD has been weakly associated
with other skeletal markers in diseases such as Gaucher’s
[1], multiple studies have discussed that osteoclast impair-
ment, the very cause of EFD, is also indicated in other forms
of bone loss and immune system crosstalk [4, 11, 12].
Clinicians under the current binary system of EFD classifica-
tion may be missing information that could improve the pre-
dictive value of EFD, and this information could be intro-
duced through the 3-point severity scale we have presented
in this study.Width ratios were previously shown acrossmany
cases to be highly accurate at EFD classification under a bi-
nary system [5], but have underperformed under our 3-point
system. From our findings across a comparably large sample
of femurs, we conclude that “volume 4–6 cm/volume 0–2 cm”
is the metric with the most utility for EFD severity distinction
and argue that subtle concavity changes between normal and
mild EFD are most likely to be missed under previous
methods of classification.
In the context of skeletal radiology practice and research,
application of our method and derivation of the proposed vol-
ume metric would enable objective and robust EFD classifi-
cation, provide a continuous clinical parameter for analyses,
and allow researchers to better understand diseases causing
EFD. Although this study was conducted on a Gaucher’s pa-
tient base, it may be extrapolated to other diseases with EFD
resulting from bone marrow expansion, as the deformity has
been reported to be consistent across these diseases (e.g.,
membranous lipodystrophy, Thalassemia, Niemann-Pick)
[1]. The findings of this study would thereby have utility
across a large number of cases.
Several study limitations are worth noting. Clinical cutoffs
by ROC curves were set to optimize the accurate detection of
mild EFD femurs, which have been least reported on and may
therefore be the most interesting to follow longitudinally.
However, further work may prove otherwise, and these clini-
cal cutoffs may therefore be subject to change. Additionally,
16 patients with discordant radiologist ratings of EFD severity
were excluded from the analysis due to an inability to stratify
into groups, and this may have led to an overestimation of the
ability of the AUCs to distinguish between severities. Thirdly,
MRI images are subject to errors based on patient positioning
[13] and may result in inaccurate determinations of volume
and width. Because EFD remains static after a certain age, we
were able to reduce error by choosing patient scan dates with
the highest-quality images. Nonetheless, this may be a source
of somemeasurement errors. Finally, a study design limitation
was incurred by the subjective selection of the slice used to
measure width and volume. Patients often had more than one
slice that suited our protocol criteria, but we sought to reduce
error by selecting slices with femur cuts that appeared consis-
tent across patients.
The findings of this study may be enhanced by automating
the segmentation of volumes and derivation of ratios.
Automatic segmentation of the femur has been widely report-
ed on in recent years and indicates strong potential for our
volume ratio measurements to become automated [14–18].
This meets the last of the criteria we set forth for this method.
Future studies should therefore seek the development of a
methodology to automatically segment distal femur ROIs for
the extraction of volume. Clinicians may eventually be able to
input an image and instantly receive information about the
degree of EFD severity, both as a continuous variable through
volume ratio and as an ordinal rating.
In conclusion, we report upon a new measurement method
based on volume ratios at the distal femur to distinguish the
Erlenmeyer flask deformity on a 3-point scale of severity. The
proposed method is highly proficient, accounts for the con-
cavity of the distal femur, produces an assessable continuous
clinical variable, and has strong potential for automation.
Radiologists studying and rating this deformity in bone mar-
row expansion diseases would benefit the most in the future
from our findings.
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